NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Kyverna

Kyverna

Public
Emeryville, CaliforniaHealthcarewww.kyvernatx.com

Last Round

Series B

Aug 3, 2023

Total Funding Raised

$60M

Company Overview

Kyverna (NAS: KYTX) is a biopharmaceutical company specializing in the development of innovative cell therapies for patients with autoimmune diseases.

Sector

Healthcare

AI Layer

Non-AI

Keywords

CAR T-cell therapy for autoimmune diseaseautologous CD19 CAR T-cell therapycell therapy for autoimmune diseaseB-cell depleting autoimmune therapyautoimmune immune system reset therapyallogeneic CD19 CAR T-cell therapylupus nephritis cell therapymultiple sclerosis cell therapyTreg-based cell therapy platformmyasthenia gravis cell therapycell therapy for rheumatologycell therapy for neurologyengineered cell therapy development

Kyverna Comps

Public and private peers based on sector, stage, and business model.

Kyverna comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kyverna Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 3, 2023
View all Funding Rounds

Kyverna Investors

Notable investors and investment history

Kyverna investors
InvestorRounds
Bain Capital Life SciencesSeries B
jVen CapitalSeries B
CAM CapitalSeries B
Westlake Village BiopartnersSeries B
GordonMD Global InvestmentsSeries B
LYFE CapitalSeries B
Vida VenturesSeries B
View all Investors

Kyverna Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kyverna Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersEmeryville, California
Employee Range155
Year Founded2018
Last FundingAug 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.